Latest news with #CHICAGO
Yahoo
9 hours ago
- Automotive
- Yahoo
Trucking Hub Selects 3MD ELD as Preferred FMCSA-Certified, Tamper-Proof Logging Solution
CHICAGO, Aug. 11, 2025 /PRNewswire/ -- Trucking Hub, an industry-leading provider of Transportation Management System (TMS) software, has named 3MD ELD its preferred electronic logging device for integrated fleet compliance. The decision underscores Trucking Hub's commitment to delivering an FMCSA-certified, tamper-proof ELD engineered for enterprise reliability, seamless TMS integration, and continuous fleet connectivity. 3MD ELD was among the first electronic logging devices in the United States to receive FMCSA certification in 2017. It combines FMCSA-compliant logging and advanced telematics in a single device, providing carriers with continuous connectivity, real-time fleet visibility, and compliance data in one place. Powered by Verizon's nationwide network, it keeps trucks connected to Trucking Hub in real time, enabling dynamic ETAs, audit-ready IFTA reports with one-minute GPS intervals, and complete operational oversight. Native integration with Trucking Hub's Transportation Management System allows carriers to manage driver logs, Hours of Service (HOS) data, compliance, and location tracking from a single platform. Both Trucking Hub and 3MD ELD are owned and operated by 3MD, a Chicago-based, family-owned business with deep roots in trucking – from local and regional operations to compliance solutions, fleet management, technology services, and software development. Operating a fleet of 30 trucks, 3MD builds and uses its own technology daily, ensuring every product meets the highest standards for reliability, security, and operational efficiency – and is always driver approved. "Carriers need an ELD they can depend on – one that's tamper-proof, FMCSA-compliant, and fully integrated into their operations," said Milos Pavlovic, Founder & CEO of Trucking Hub. "3MD ELD delivers exactly that, with enterprise-grade hardware, continuous connectivity, and direct TMS integration that give fleets the control they need to perform at the highest level." About Trucking Hub Trucking Hub is a Chicago-based technology leader providing comprehensive transportation management system (TMS) solutions for trucking companies. Built by truckers for truckers, Trucking Hub delivers practical, scalable solutions rooted in real-world trucking operations. To get started with a 30-day trial or request a demo, visit or contact our sales team at +1 877 287 8250. About 3MD ELD 3MD ELD is an FMCSA-certified electronic logging device trusted nationwide for its tamper-proof design, reliability, and advanced compliance features. Operated by 3MD, the solution integrates natively with Trucking Hub's TMS to deliver seamless compliance, telematics, continuous connectivity, and operational efficiency for fleets of any size. To get started with a 30-day trial or request a demo, visit or contact their sales team at +1 877 ELD LOGS. Contact Trucking Hubsales@ View original content to download multimedia: SOURCE Trucking Hub Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
9 hours ago
- Automotive
- Associated Press
Trucking Hub Selects 3MD ELD as Preferred FMCSA-Certified, Tamper-Proof Logging Solution
CHICAGO, Aug. 11, 2025 /PRNewswire/ -- Trucking Hub, an industry-leading provider of Transportation Management System (TMS) software, has named 3MD ELD its preferred electronic logging device for integrated fleet compliance. The decision underscores Trucking Hub's commitment to delivering an FMCSA-certified, tamper-proof ELD engineered for enterprise reliability, seamless TMS integration, and continuous fleet connectivity. 3MD ELD was among the first electronic logging devices in the United States to receive FMCSA certification in 2017. It combines FMCSA-compliant logging and advanced telematics in a single device, providing carriers with continuous connectivity, real-time fleet visibility, and compliance data in one place. Powered by Verizon's nationwide network, it keeps trucks connected to Trucking Hub in real time, enabling dynamic ETAs, audit-ready IFTA reports with one-minute GPS intervals, and complete operational oversight. Native integration with Trucking Hub's Transportation Management System allows carriers to manage driver logs, Hours of Service (HOS) data, compliance, and location tracking from a single platform. Both Trucking Hub and 3MD ELD are owned and operated by 3MD, a Chicago-based, family-owned business with deep roots in trucking – from local and regional operations to compliance solutions, fleet management, technology services, and software development. Operating a fleet of 30 trucks, 3MD builds and uses its own technology daily, ensuring every product meets the highest standards for reliability, security, and operational efficiency – and is always driver approved. 'Carriers need an ELD they can depend on – one that's tamper-proof, FMCSA-compliant, and fully integrated into their operations,' said Milos Pavlovic, Founder & CEO of Trucking Hub. '3MD ELD delivers exactly that, with enterprise-grade hardware, continuous connectivity, and direct TMS integration that give fleets the control they need to perform at the highest level.' About Trucking Hub Trucking Hub is a Chicago-based technology leader providing comprehensive transportation management system (TMS) solutions for trucking companies. Built by truckers for truckers, Trucking Hub delivers practical, scalable solutions rooted in real-world trucking operations. To get started with a 30-day trial or request a demo, visit or contact our sales team at +1 877 287 8250. About 3MD ELD 3MD ELD is an FMCSA-certified electronic logging device trusted nationwide for its tamper-proof design, reliability, and advanced compliance features. Operated by 3MD, the solution integrates natively with Trucking Hub's TMS to deliver seamless compliance, telematics, continuous connectivity, and operational efficiency for fleets of any size. To get started with a 30-day trial or request a demo, visit or contact their sales team at +1 877 ELD LOGS. Contact Trucking Hub [email protected] 877-287-8250 View original content to download multimedia: SOURCE Trucking Hub
Yahoo
6 days ago
- Business
- Yahoo
Kemper Announces $500 Million Share Repurchase Authorization and Quarterly Dividend
CHICAGO, August 05, 2025--(BUSINESS WIRE)--Kemper Corporation (NYSE: KMPR) announced today that its Board of Directors has approved a new share repurchase authorization, under which the Company can repurchase up to $500 million of its common stock. Repurchases may be made from time to time at the Company's discretion, subject to market conditions and other factors. In addition, Kemper also announced that its Board of Directors has declared a quarterly dividend of $0.32 per share. The dividend is payable on September 2, 2025, to Kemper's shareholders of record as of August 18, 2025. "We remain committed to a disciplined capital strategy that balances both near- and long-term value creation," said Joseph P. Lacher, Jr., President and CEO. "The new share repurchase authorization and our continuing dividend demonstrate the strength of Kemper's financial position and our confidence in the underlying performance of the business." About Kemper The Kemper family of companies is one of the nation's leading specialized insurers. With approximately $13 billion in assets, Kemper is improving the world of insurance by providing affordable and easy-to-use personalized solutions to individuals, families and businesses through its Kemper Auto and Kemper Life brands. Kemper serves over 4.7 million policies, is represented by approximately 24,000 agents and brokers, and has approximately 7,500 associates dedicated to meeting the ever-changing needs of its customers. Learn more about Kemper. View source version on Contacts Investors: Michael Marinaccio, 312.661.4930, investors@ Media: Barbara Ciesemier, 312.661.4521, bciesemier@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Globe and Mail
04-08-2025
- Business
- Globe and Mail
Vivid Seats Announces Reverse Stock Split
CHICAGO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (NASDAQ: SEAT) ('Vivid Seats'), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, today announced a 1-for-20 reverse stock split of its Class A and Class B common stock (the 'Reverse Stock Split'), effective at 5:00 p.m. Eastern Time on August 5, 2025. The Class A common stock will begin trading on the Nasdaq Global Select Market on a split-adjusted basis under the existing ticker symbol 'SEAT' when the market opens on August 6, 2025. The new CUSIP number for the Class A common stock following the Reverse Stock Split is 92854T209. The Reverse Stock Split was approved by Vivid Seats' stockholders on July 21, 2025, with the final ratio subsequently determined by Vivid Seats' Board of Directors. As a result of the Reverse Stock Split, every 20 shares of common stock will automatically be combined into one share of common stock. Class A stockholders who would otherwise be entitled to receive a fractional share will instead be entitled to receive, in lieu thereof, a cash payment. The Reverse Stock Split will not affect any stockholder's percentage ownership interest or voting power in Vivid Seats, other than as a result of the treatment of fractional shares. All of Vivid Seats' outstanding warrants, including its public warrants trading on the Nasdaq Global Select Market under the ticker symbol 'SEATW,' and equity-based awards will be proportionately adjusted (including applicable exercise prices) in accordance with their respective terms. Vivid Seats' transfer agent, Continental Stock Transfer & Trust Company, is acting as the exchange agent for the Reverse Stock Split. Stockholders who hold their shares electronically in book-entry form will receive a transaction statement indicating the number of shares held after the Reverse Stock Split, along with a cash payment in lieu of any fractional shares. Stockholders who hold their shares through a bank, broker, or other nominee will have their positions adjusted to reflect the Reverse Stock Split, and receive a cash payment in lieu of any fractional shares, in accordance with the processes of their respective bank, broker, or nominee. More information regarding the Reverse Stock Split can be found in Vivid Seats' definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on July 11, 2025. About Vivid Seats Founded in 2001, Vivid Seats is a leading online ticket marketplace committed to becoming the ultimate partner for connecting fans to the live events, artists, and teams they love. Based on the belief that everyone should ' Experience It Live,' the Chicago-based company provides exceptional value by providing one of the widest selections of events and tickets in North America and an industry leading Vivid Seats Rewards program where all fans earn on every purchase. Through its proprietary software and unique technology, Vivid Seats drives the consumer and business ecosystem for live event ticketing and enables the power of shared experiences to unite people. Vivid Seats has been recognized by Newsweek as one of America's Best Companies for Customer Service in ticketing. Fans who want to have the best live experiences can start by downloading the Vivid Seats mobile app, going to or calling 866-848-8499. Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of the 'safe harbor' provisions of the U.S. Private Securities Litigation Reform Act of 1995. Words such as 'anticipate,' 'believe,' 'can,' 'continue,' 'could,' 'design,' 'estimate,' 'expect,' 'forecast,' 'future,' 'goal,' 'intend,' 'likely,' 'may,' 'plan,' 'project,' 'propose,' 'seek,' 'should,' 'target,' 'will,' and 'would,' as well as similar expressions which predict or indicate future events and trends or which do not relate to historical matters, are intended to identify such forward-looking statements. The forward-looking statements in this press release relate to, without limitation, the timing of the Reverse Stock Split and its impact on Vivid Seats' stockholders. Forward-looking statements are not guarantees of future performance, conditions, or results, and are subject to risks, uncertainties, and assumptions that can be difficult to predict and/or are outside of Vivid Seats' control. Therefore, actual results may differ materially from those contemplated by any forward-looking statements. Important factors that could cause or contribute to such differences include, but are not limited to, Vivid Seats' ability to implement the Reverse Stock Split on the anticipated timing or at all, Vivid Seats' ability to achieve the anticipated benefits of the Reverse Stock Split, and other factors discussed in the 'Risk Factors' and 'Management's Discussion and Analysis of Financial Condition and Results of Operations' sections of Vivid Seats' most recent Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q, and other filings with the Securities and Exchange Commission. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release. Except as required by applicable law, Vivid Seats undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Contacts: Investors Kate Africk Media Julia Young
Reuters
24-07-2025
- Health
- Reuters
Medical groups and US states work to circumvent Kennedy's vaccine decisions
CHICAGO, July 24 (Reuters) - U.S. health secretary Robert F. Kennedy Jr.'s changes to federal vaccine policy are prompting medical organizations and several states to formulate their own vaccine recommendations for the fall respiratory illness season, concerned many healthy children and pregnant women could lose access to preventive shots. This push for an alternative standard to the one set by the federal government runs the risk of increasing confusion among providers and patients, according to health experts. It also runs up against hundreds of laws at the state level that rely on a federal vaccine advisory panel, the experts said. The Advisory Committee on Immunization Practices, or ACIP, advises the U.S. Centers for Disease Control and Prevention on which people should receive vaccines and at what intervals after they are approved by the Food and Drug Administration. Kennedy has spent decades sowing doubts about vaccines even when contradicted by scientific evidence. Since being appointed by Republican President Donald Trump to head the U.S. Department of Health and Human Services, or HHS, Kennedy has upended the federal government's process for recommending vaccines for the American public. Kennedy last month fired all 17 ACIP members, replacing them with hand-picked advisers including anti-vaccine activists. Prior to that, Kennedy in May withdrew a federal recommendation for COVID shots for pregnant women and healthy children without ACIP's input, saying there was not enough evidence to support offering these boosters to healthy children. Leading U.S. medical organizations including the American Academy of Pediatrics, known as AAP, and the Infectious Diseases Society of America, called IDSA, have sued Kennedy over the COVID decision. AAP said it will promote its own evidence-based vaccine guidelines starting with the fall respiratory season for COVID, influenza and respiratory syncytial virus, or RSV. "We simply cannot and will not stay silent as the system we rely on is being intentionally dismantled," Dr. Sue Kressly, the academy's president, told Reuters. The American College of Obstetricians and Gynecologists, called ACOG, is also developing guidelines for the upcoming respiratory illness season, to be issued in August or September. An ACOG spokesperson said the organization continues to recommend COVID vaccines for pregnant women, a group at increased risk for severe COVID and pregnancy complications. The spokesperson also said the organization rejects a recommendation by Kennedy's vaccine panel against flu shots containing thimerosal, a mercury-containing preservative that vaccine skeptics long have sought to link to autism despite evidence that these vaccines are safe. Both organizations and several others including the IDSA are collaborating with the Vaccine Integrity Project, a group of public health and infectious disease experts formed amid concerns about changes to vaccine policy, to review the latest scientific evidence on licensed vaccines for use in their guidelines. "What we're trying to do is add a piece of non-biased, authoritative review of the data for use by the (medical) societies," said Dr. Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota, who served as an adviser to Democratic former President Joe Biden on COVID. An HHS spokesperson defended Kennedy's actions, saying the newly configured panel brings "fresh, independent scientific judgment" and that ACIP "will continue to be the statutory authority guiding immunization policy in this country." Jen Kates, a senior analyst at the nonprofit health policy organization KFF, said U.S. states have always maintained a patchwork of health policies. But having multiple entities issuing vaccine recommendations at the state and federal levels could make it hard for parents to know who to trust, according to Kates. "This patchwork could become even more pronounced with significant implications for health. State laws and requirements may vary, but pathogens don't abide by borders," Kates said. Recommendations issued by ACIP since its founding in 1964 have become embedded in laws across the United States governing health insurance coverage, access to vaccines for children in low-income families, school immunizations, the ability of pharmacists to administer vaccines, and, in some states, vaccine purchasing. "It is mind-numbing when you compare how many things are impacted by ACIP," said Rebecca Coyle, who serves as executive director of the American Immunization Registry Association, an organization that develops and updates vaccination information systems used by physicians, and as an adviser to ACIP. An analysis by the Association of State and Territorial Health Officials found that nearly 600 statutes and regulations across 49 of the 50 U.S. states, three U.S. territories and Washington, D.C., reference ACIP recommendations. Several states have already taken action. Wisconsin said it continues to recommend the current COVID vaccine during pregnancy and for everyone age 6 months and older, and noted that the state's Medicaid health program for low-income people will continue to cover the shot for eligible people. The Democratic governors of California, Washington state and Oregon condemned Kennedy's dismissal of the ACIP panel members, citing their "grave concerns" about the integrity and transparency of upcoming federal vaccine recommendations. These states said they will continue to recommend COVID vaccines for children 6 months and older and pregnant women in accord with leading U.S. medical associations. Some states have started rewriting statutes to no longer defer exclusively to ACIP. Colorado, for instance, has amended laws to include vaccine recommendations from major medical societies in addition to ACIP when setting the state's policies for immunizing schoolchildren. Massachusetts lawmakers are considering legislation proposed by Democratic Governor Maura Healey to empower the state's public health commissioner to determine routine childhood immunizations in lieu of ACIP's recommendations. Legislators in Maine have removed references to ACIP from a state vaccine access law. Osterholm said health insurers have told the Vaccine Integrity Project that they would be more likely to cover uniform vaccine recommendations, increasing pressure for alignment among various groups. "We need to come together the best we can," Osterholm said, but "we can't leave the ACIP or HHS recommendations as the only other source out there."
